- Home
- EMD vs MLAB Comparison
EMD vs MLAB Comparison
Compare EMD & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMD
- MLAB
- Stock Information
- Founded
- EMD 2003
- MLAB 1982
- Country
- EMD United States
- MLAB United States
- Employees
- EMD N/A
- MLAB N/A
- Industry
- EMD Finance/Investors Services
- MLAB Industrial Machinery/Components
- Sector
- EMD Finance
- MLAB Industrials
- Exchange
- EMD Nasdaq
- MLAB Nasdaq
- Market Cap
- EMD 587.7M
- MLAB 524.2M
- IPO Year
- EMD N/A
- MLAB N/A
- Fundamental
- Price
- EMD $10.17
- MLAB $76.50
- Analyst Decision
- EMD
- MLAB Hold
- Analyst Count
- EMD 0
- MLAB 2
- Target Price
- EMD N/A
- MLAB $130.00
- AVG Volume (30 Days)
- EMD 248.5K
- MLAB 126.8K
- Earning Date
- EMD 01-01-0001
- MLAB 08-05-2025
- Dividend Yield
- EMD 10.25%
- MLAB 0.85%
- EPS Growth
- EMD N/A
- MLAB N/A
- EPS
- EMD N/A
- MLAB N/A
- Revenue
- EMD N/A
- MLAB $240,978,000.00
- Revenue This Year
- EMD N/A
- MLAB $6.45
- Revenue Next Year
- EMD N/A
- MLAB $5.80
- P/E Ratio
- EMD N/A
- MLAB N/A
- Revenue Growth
- EMD N/A
- MLAB 11.47
- 52 Week Low
- EMD $7.85
- MLAB $67.95
- 52 Week High
- EMD $9.55
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- EMD 59.00
- MLAB 36.48
- Support Level
- EMD $10.06
- MLAB $72.43
- Resistance Level
- EMD $10.13
- MLAB $80.40
- Average True Range (ATR)
- EMD 0.07
- MLAB 3.59
- MACD
- EMD -0.01
- MLAB 0.82
- Stochastic Oscillator
- EMD 77.27
- MLAB 49.69
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.